BioCentury
ARTICLE | Company News

Management tracks: Gritstone, Disarm, Symic

January 24, 2018 12:44 AM UTC

Cancer immunotherapy company Gritstone Oncology Inc. (Emeryville, Calif.) hired Jean-Marc Bellemin as CFO and EVP of finance. He was CFO and SVP of the Actelion Pharmaceuticals U.S. division of Actelion Ltd., which Johnson & Johnson (NYSE:JNJ) acquired.

Axon degeneration company Disarm Therapeutics Inc. (Cambridge, Mass.) hired Thomas Engber as SVP and head of neuropharmacology and translational sciences. He was the senior director of the Center for External Innovation at Takeda Pharmaceutical Co. Ltd. (Tokyo:4502)...